Valganciclovir

C. diff Risk

None

Oral Bioavailability

Moderate

Approximate Cost

$46.84 (Maintenance)
$93.68 (Induction)

Dosing

Prophylaxis/Maintenance Dose900 mg PO q24h

Treatment/Induction Dose900 mg PO q12h

General Information

Common Usage

CMV treatment and prophylaxis

Drug Monitoring

CBC-differential and renal function periodically.

Major Interactions

  • May cause blood dyscrasias: granulocytopenia, anemia, thrombocytopenia, and aplastic anemia.

  • Acute kidney injury

Tablet/Capsule Strengths

Special Authorization required

Additional Information

EH prescribing restrictions:
None

NLPDP status:
Special Authorization Required

May require IV ganciclovir if recommended dose is less than 450 mg.

Valganciclovir tablets should be administered whole and not crushed or split.

Hazardous drug. Contact Pharmacy.